SPDR S&P Pharmaceuticals shares owned by U.S. Capital Wealth Advisors
Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by U.S. Capital Wealth Advisors
from 13F filings
Historical chart of U.S. Capital Wealth Advisors investment in SPDR S&P Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including SPDR S&P Pharmaceuticals held by U.S. Capital Wealth Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in SPDR S&P Pharmaceuticals by U.S. Capital Wealth Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $706k | 15k | 47.94 |
| 2025-06-30 | $582k | 14k | 40.58 |
| 2025-03-31 | $644k | 15k | 43.80 |
| 2024-12-31 | $847k | 20k | 42.99 |
| 2024-09-30 | $991k | 22k | 44.36 |
| 2024-06-30 | $719k | 18k | 39.78 |
| 2024-03-31 | $541k | 13k | 43.13 |
| 2023-12-31 | $495k | 12k | 41.62 |
| 2022-12-31 | $45k | 1.1k | 40.95 |
More positions owned by U.S. Capital Wealth Advisors
View all positions for U.S. Capital Wealth Advisors